Vericel Corp (VCEL)
46.05
+0.60
(+1.32%)
USD |
NASDAQ |
Apr 26, 16:00
46.05
0.00 (0.00%)
After-Hours: 20:00
Vericel Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.1829 |
| June 30, 2018 | 0.1906 |
| March 31, 2018 | 0.8238 |
| December 31, 2017 | 0.7648 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.5949 |
| June 30, 2017 | 0.7273 |
| March 31, 2017 | 0.6544 |
| December 31, 2016 | 0.4099 |
| September 30, 2016 | 0.4922 |
| June 30, 2016 | 0.1377 |
| March 31, 2016 | 0.0032 |
| December 31, 2015 | 0.0032 |
| September 30, 2015 | 0.0031 |
| June 30, 2015 | 0.003 |
| March 31, 2015 | 0.0032 |
| December 31, 2014 | 0.0031 |
| September 30, 2014 | 0.004 |
| June 30, 2014 | 0.8977 |
| March 31, 2014 | 0.0005 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.002 |
| June 30, 2013 | 0.0103 |
| March 31, 2013 | 0.0046 |
| December 31, 2012 | 0.0042 |
| September 30, 2012 | -0.002 |
| June 30, 2012 | -0.0028 |
| March 31, 2012 | -0.0032 |
| December 31, 2011 | -0.0062 |
| September 30, 2011 | -0.009 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2019
--
Maximum
Jun 2019
--
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals Inc | 0.6243 |
| Arbutus Biopharma Corp | 0.00 |
| Chimerix Inc | 0.0006 |
| Karyopharm Therapeutics Inc | -1.255 |
| Y-mAbs Therapeutics Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 353.66M |
| Total Liabilities (Quarterly) | 127.70M |
| Shareholders Equity (Quarterly) | 225.95M |
| Current Ratio | 4.495 |